ICU
Income statement / Annual
Last year (2025), SeaStar Medical Holding Corp's total revenue was $1.23 M,
an increase of 814.07% from the previous year.
In 2025, SeaStar Medical Holding Corp's net income was -$12.15 M.
See SeaStar Medical Holding Corp,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$1.23 M |
$135.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$53.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$1.18 M
|
$135.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.96
|
1
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$7.52 M
|
$9.11 M
|
$5.97 M
|
$2.50 M
|
$2.77 M
|
$4.03 M
|
| General & Administrative Expenses |
$5.84 M
|
$8.87 M
|
$8.01 M
|
$6.92 M
|
$1.68 M
|
$2.36 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$32.00 K
|
$0.00
|
$0.00
|
$65.00 K
|
| Selling, General & Administrative Expenses |
$5.84 M
|
$8.87 M
|
$8.04 M
|
$6.92 M
|
$1.68 M
|
$2.43 M
|
| Other Expenses |
$0.00
|
$0.00
|
$200.00 K
|
$2.19 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.36 M
|
$17.98 M
|
$14.21 M
|
$11.61 M
|
$4.45 M
|
$6.45 M
|
| Cost And Expenses |
$13.41 M
|
$17.98 M
|
$14.21 M
|
$11.61 M
|
$4.45 M
|
$6.45 M
|
| Interest Income |
$325.00 K
|
$101.00 K
|
$0.00
|
$630.00
|
$0.00
|
$0.00
|
| Interest Expense |
$329.00 K
|
$244.00 K
|
$1.08 M
|
$630.00 K
|
$212.00 K
|
$3.31 M
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$14.01 M
|
$0.00
|
$0.00
|
$6.45 M
|
| EBITDA |
-$12.18 M |
-$24.58 M |
-$11.14 M |
-$11.56 M |
-$4.39 M |
$0.00 |
| EBITDA Ratio |
-9.87
|
-182.1
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-9.87
|
-132.16
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$28.00 K
|
-$6.99 M
|
-$12.02 M
|
-$580.00 K
|
-$148.00 K
|
$3.19 M
|
| Income Before Tax |
-$12.15 M
|
-$24.83 M
|
-$26.23 M
|
-$12.19 M
|
-$4.60 M
|
-$3.27 M
|
| Income Before Tax Ratio |
-9.84
|
-183.9
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$3.00 K
|
$3.00 K
|
$0.00
|
$1.00 K
|
-$1.00 K
|
$9.00 K
|
| Net Income |
-$12.15 M
|
-$24.83 M
|
-$26.23 M
|
-$12.19 M
|
-$4.60 M
|
-$3.28 M
|
| Net Income Ratio |
-9.85
|
-183.93
|
0
|
0
|
0
|
0
|
| EPS |
-5.86 |
-66.3 |
-302.62 |
-233.8 |
-88.1 |
-0.1 |
| EPS Diluted |
-5.86 |
-66.3 |
-302.62 |
-233.8 |
-88.1 |
-0.1 |
| Weighted Average Shares Out |
$20.73 M
|
$374.40 K
|
$86.68 K
|
$52.13 K
|
$52.16 K
|
$52.16 K
|
| Weighted Average Shares Out Diluted |
$20.73 M
|
$374.40 K
|
$86.68 K
|
$52.13 K
|
$52.16 K
|
$52.16 K
|
| Link |
|
|
|
|
|
|
